News

Dirk Meissner und Ingo Sauer verstärken das Linkando-Team in den Bereichen Datenschutz und Sicherheit

Landau, 26. September 2019 - Um auch zukünftig den bestmöglichen Schutz und DSGVO-konformen Umgang mit sensiblen Daten gewährleisten zu können, hat Linkando jetzt zwei Koryphäen aus den Bereichen Datenschutz und Cyber-Security an Bord geholt: den Datenschutzexperten Dirk Meissner sowie den Security-Spezialisten Ingo Sauer.

Damit reagiert Linkando auf die steigenden Anforderungen im Umgang mit personenbezogenen Daten sowie auf die Zunahme von Cyberattacken gegen Clouddienste und Unternehmen, auch wenn Linkando selbst noch nie von einem Cyberangriff betroffen war. Der Software-Anbieter will sicherstellen, dass seine Kunden, die im In- und Ausland die digitalen Workspaces von Linkando für ihre Zusammenarbeit nutzen, optimal geschützt sind.

Volker Wiora, Geschäftsführer der Linkando GmbH: "Als Startup sind wir im Grunde noch nicht dazu verpflichtet, die höchsten Anforderungen der DSGVO bereits jetzt zu erfüllen, aber es entspricht unserem Selbstverständnis, unseren Kunden und deren Daten maximale Sicherheit und Datenschutz zu bieten. Deshalb haben wir uns mit Dirk Meissner und Ingo Sauer Spezialisten mit einer herausragenden Expertise geholt, die sich mit den Herausforderungen und Rahmenbedingungen des Datenschutzes und von Cyber Security bestens auskennen."

The US$ 1.78 billion actigraphy sensor and PSG devices market on course to grow at 4.3% in 2019, according to Fact.MR’s latest analysis. According to the study, actigraphy sensor and PSG devices market remains a highly consolidated landscape, with Tier I companies maintaining their hegemony despite the foray of new entrants.

According to the study, as a result of the convergence of healthcare and technology, new medical technology (MedTech) products are gaining ground. Growing consumer awareness about—and inclination towards—technologically advanced actigraphy sensor and PSG devices has attracted both, tech industry leaders and startups, to enter the healthcare industry with more innovative actigraphy sensor and PSG devices.

“Ongoing developments and research in the field of sleep disease diagnostics and management reflect in the huge scope of innovation in actigraphy sensor and PSG devices. New entrants are aiming to capitalize on potential opportunities in the actigraphy sensor and PSG devices market by jumping on the technology bandwagon,” says the Fact.MR report.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2829

According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from dyslipidemia therapeutics worldwide in 2018. As high LDL levels have been associated with increased risks of heart attacks, strokes, and other cardiovascular problems in humans, governments around the world are launching various campaigns to raise awareness about the adverse impact of high LDL levels in the blood.

The growing prevalence of cardiovascular disorders worldwide has prompted individuals to effectively manage their LDL levels. To capitalize on the current trends prevalent in the dyslipidemia therapeutics market, pharmaceutical companies continue to strive towards developing new and improved therapies to lower LDL levels, and effectively manage the percentage of other lipids in the blood. A range of new treatments such as combination therapies, gene editing, and novel target drugs are under development, particularly for dyslipidemia therapeutics.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2928

Statins Persist as Preferred Drug Class for Dyslipidemia Therapeutics

According to a recent study of Fact.MR, the natural cold, cough, and sore throat remedies market is expected to surpass revenues worth US$ 4,800 Mn in 2019. The rising popularity of alternative medicine and therapies, coupled with the widespread adoption of natural medication in healthcare worldwide are key factors that are fueling growth of the natural cold, cough, and sore throat remedies market.

The study opines that natural syrups and drops will continue to hold nearly half share of the market, accounting for revenues worth over US$ 2,200 Mn in 2018. The palatable taste of syrups and the presence of multiple ingredients deemed to boost the overall immunity, while combating cold and cough, are pivotal reasons behind increased traction for natural syrups & drops. For instance, sales of Nin Jiom Pei Pa Koa, a Chinese herbal syrup for treating cough, witnessed a significant surge in sales in the US during the flu season in 2018, not only because it was effective but also because consumers found the syrup’s taste surprisingly pleasant.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2988

Version 13.1 mit zahlreichen neuen Funktionen für noch mehr Schutz vor Malware, Phishing und CEO-Fraud. Premiere des neuen SaaS-Angebots für Partner.

Neue Version von NoSpamProxy und SaaS-Angebot für Partner auf der it-sa

Paderborn, 26. September 2019 - Net at Work GmbH, der Hersteller der modularen Secure-Mail-Gateway-Lösung NoSpamProxy aus Paderborn, zeigt auf der Security-Messe it-sa die Version 13.1 der Mail-Security-Suite NoSpamProxy, die zahlreiche Verbesserungen bietet und für den SaaS-Betrieb optimiert wurde. Auf dieser Basis bietet Net at Work künftig Partnern, die den Aufbau und Betrieb eines Managed Services für ihre Kunden scheuen, einen eigenen Cloud Service an.

NoSpamProxy in Version 13.1

Die Schule des Geldes und der Vermögensclub

Schwarzheide, 26.09.2019: "Immer mehr Menschen holen sich Lebensmittel bei der Tafel", "Armutsrisiko ist in Bremen am höchsten" oder "Was am Ende übrig bleibt" - das sind Schlagzeilen aus den deutschen Medien, aus einem der reichsten Länder der Welt. Zum Sparen kommt "der kleine Mann" schon lange nicht mehr. Er kämpft um das nackte Überleben. Lebensversicherungen oder Sparbücher taugen nicht mehr für die Altersversorgung. Nullzins und Minuszins versauen uns den gemütlichen Lebensabend.

Die Schule des Geldes

R+V-Studie "Die Ängste der Deutschen 2019"

Wiesbaden, 26. September 2019. Reicht die Rente noch zum Leben oder müssen künftige Ruheständler jeden Cent dreimal umdrehen? Die Furcht vor der Altersarmut ist groß. Wie die repräsentative R+V-Studie "Die Ängste der Deutschen 2019" zeigt, befürchtet jeder dritte Bundesbürger, dass er sich im Alter nichts mehr leisten kann.

Bürger sorgen sich um ihren Lebensstandard
Seit 1992 befragt das Infocenter der R+V Versicherung jährlich rund 2.400 Menschen nach ihren größten Ängsten rund um Politik, Wirtschaft, Umwelt, Familie und Gesundheit. "Mit dem Thema Altersarmut beschäftigen wir uns von Beginn an. Ein Blick auf den Langzeitvergleich zeigt, dass sich durchgehend mehr als jeder dritte Befragte dafür fürchtete, dass sein Lebensstandard im Alter sinkt", sagt Brigitte Römstedt, Leiterin des R+V-Infocenters. "In wirtschaftlich schwierigen Zeiten kletterte diese Angst oft sogar über die 40-Prozent-Marke."

According to a recent Fact.MR study, the genealogy products and services market is likely to be valued at over US$ 3 billion in 2019. The market is likely to continue its bullish run with a myriad of factors influencing the strategy of key players. Surging demand for genetic and DNA testing in an assortment of industries, coupled with the growing awareness about genealogy are some of the vital factors bolstering market growth. Technological advancement also remains a key influencer, as efficient data storage and retrieval become key priorities for market players.

Demand for genealogy in tracing lineage and creating family trees is on the rise with service providers using aggressive marketing techniques to draw in new consumers. Commercials promoting self-discovery through lineage tracing are increasingly finding greater appeal as they resonate with the human psychology of tracing their heritage in order to gain a sense of wider connection. Additionally, the concept is being popularized by an array of television programs such as “Who Do You Think You Are?” and features providing information about the ancestry of famous personalities and linking it to their career and life.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3083

The lithotripsy devices market is projected to continue its steady growth due to the burgeoning cases of kidney stones, coupled with the surging demand for minimally invasive medical treatments. According to Fact.MR report, the lithotripsy devices market is anticipated to accelerate at 4.3% CAGR during 2018-2026 to reach a value of US$ 1,095.2 MN by the end of 2026. In recent past, lithotripsy has become the most preferred way of treating kidney stones, owing to myriad advantages of lithotripsy devices, such as low cost, relative safety, negligible recovery time and positive results.

The Fact.MR report on lithotripsy devices market opines that the growing adoption of lithotripsy devices owing to their ability to treat all kinds of kidney stones with impressive success rates for ureteral stones without any considerable complications has been underpinning gains in lithotripsy devices market.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3084

Surging Incidence of Urolithiasis to Boost Sales of Lithotripsy Devices

Increasing cognizance of infections acquired in hospitals in parallel to the rising cases of surgical-site infections (SSI) is considered significant driver underpinning the growth of the global antiseptic bathing market. According to a recent report published by Fact.MR, the global antiseptic bathing market is projected to surpass a value of US$ 549.3 Mn and a promising CAGR of 2.9% by the end of 2026.

There has been a substantial increase in the recommendation of regulatory bodies and healthcare authorities for the utilization of antiseptic bathing products for preoperative skin cleansing. For instance, the regulatory authorities such as Care Bundles and Royal College of Surgeons suggest the utilization of soap for skin cleansing prior to any surgery. In addition to this, the USA Institute of Healthcare Improvement approves of the Chlorhexidine Gluconate (CHG) soap specifically for the preoperative skin cleansing practices.